Abstract
Purpose: GD2 is highly expressed in neuroblastoma (NB) and specifically recognized by monoclonal antibody ch14.18/CHO (Ab). Immunotherapy with bolus infusion of ch14.18 effectively prolonged survival. We piloted a treatment with continuous infusion of ch14.18 in combination with IL2 aiming at a reduction of toxicity and maintaining immune modulation.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
